Read the latest news from Saama.
Suite of AI-enhanced SaaS solutions automates routine processes and provides a holistic view of trial operations and patient behaviors in real time.
CAMPBELL, Calif.–(BUSINESS WIRE)–Businesses quickly accumulate data, and often leave those records siloed instead of converging them into a critical asset that enables operations. According to
CAMPBELL, CA – (August 10, 2022) – Saama Technologies, LLC. (“Saama”) today announced a multi-year agreement with Merck, known as MSD outside the United States
Saama Appoints Scott Rogers as Company’s Chief Financial Officer Scott brings a unique combination of financial and clinical fused with growth experience to Saama New
CAMPBELL, CA – (November 19, 2021) – Saama Technologies, LLC. (“Saama”) today announced the appointment of six individuals to its Board of Directors. Saama board
Carlyle and co-investors including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund (“Merck GHI”), McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health Partners
Saama’s customized cloud strategy aligned with AWS Saama Smart Applications for fast-tracked clinical innovation supported by AWS Saama ensures faster, safer clinical development via AWS
List compiled by David Shulkin, M.D., 9th Secretary of the US Department of Veteran Affairs Saama honored in Drug Development and Clinical Trials category Saama’s
CAMPBELL, CA – (October 26, 2020) – Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, announced today the launch of the new
